CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 2002; 52:195
doi: 10.3322/canjclin.52.4.195
© 2002 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Freely available CME: Take the course for this article:
Oral Cancer and Precancerous Lesions
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neville, B. W.
Right arrow Articles by Day, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neville, B. W.
Right arrow Articles by Day, T. A.

Oral Cancer and Precancerous Lesions

Brad W. Neville, DDS and Terry A. Day, MD, FACS

Dr. Neville is Professor and Director, Division of Oral and Maxillofacial Pathology, Department of Stomatology, College of Dental Medicine, Medical University of South Carolina, Charleston, SC.
Dr. Day is Associate Professor and Director, Division of Head and Neck Oncologic Surgery, Department of Otolaryngology, Head and Neck Surgery, College of Medicine, Medical University of South Carolina, Charleston, SC.

In the United States, cancers of the oral cavity and oropharynx represent approximately three percent of all malignancies in men and two percent of all malignancies in women. The American Cancer Society estimates that 28,900 new cases of oral cancer will be diagnosed in 2002, and nearly 7,400 people will die from this disease. Over 90 percent of these tumors are squamous cell carcinomas, which arise from the oral mucosal lining. In spite of the ready accessibility of the oral cavity to direct examination, these malignancies still are often not detected until a late stage, and the survival rate for oral cancer has remained essentially unchanged over the past three decades. The purpose of this article is to review the clinical features of oral cancer and premalignant oral lesions, with an emphasis on early detection.




This article has been cited by other articles:


Home page
Am. J. Public HealthHome page
D. E. Morse, W. J. Psoter, T. De La Torre Feliciano, G. Cruz, and N. Figueroa
Detection of Very Early Oral Cancers in Puerto Rico
Am J Public Health, July 1, 2008; 98(7): 1200 - 1202.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. E. Diamond, L. Sun, A. J. Ottaviano, M. J. Joseph, and H. G. Munshi
Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium
J. Cell Sci., July 1, 2008; 121(13): 2197 - 2207.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. R. Mallery, J. C. Zwick, P. Pei, M. Tong, P. E. Larsen, B. S. Shumway, B. Lu, H. W. Fields, R. J. Mumper, and G. D. Stoner
Topical Application of a Bioadhesive Black Raspberry Gel Modulates Gene Expression and Reduces Cyclooxygenase 2 Protein in Human Premalignant Oral Lesions
Cancer Res., June 15, 2008; 68(12): 4945 - 4957.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
R. Ralhan, L. V. DeSouza, A. Matta, S. Chandra Tripathi, S. Ghanny, S. Datta Gupta, S. Bahadur, and K. W. M. Siu
Discovery and Verification of Head-and-neck Cancer Biomarkers by Differential Protein Expression Analysis Using iTRAQ Labeling, Multidimensional Liquid Chromatography, and Tandem Mass Spectrometry
Mol. Cell. Proteomics, June 1, 2008; 7(6): 1162 - 1173.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. S. Shumway, L. A. Kresty, P. E. Larsen, J. C. Zwick, B. Lu, H. W. Fields, R. J. Mumper, G. D. Stoner, and S. R. Mallery
Effects of a Topically Applied Bioadhesive Berry Gel on Loss of Heterozygosity Indices in Premalignant Oral Lesions
Clin. Cancer Res., April 15, 2008; 14(8): 2421 - 2430.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
L. Sun, M. E. Diamond, A. J. Ottaviano, M. J. Joseph, V. Ananthanarayan, and H. G. Munshi
Transforming Growth Factor-{beta}1 Promotes Matrix Metalloproteinase-9-Mediated Oral Cancer Invasion through Snail Expression
Mol. Cancer Res., January 1, 2008; 6(1): 10 - 20.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Wang, M. R. Spitz, J. J. Lee, M. Huang, S. M. Lippman, and X. Wu
Nucleotide Excision Repair Pathway Genes and Oral Premalignant Lesions
Clin. Cancer Res., June 15, 2007; 13(12): 3753 - 3758.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
A. C. Chi, P. R. Lambert III, Y. Pan, R. Li, D.-T. Vo, E. Edwards, P. Gangarosa, and B. W. Neville
Is alveolar ridge keratosis a true leukoplakia?: A clinicopathologic comparison of 2,153 lesions
J Am Dent Assoc, May 1, 2007; 138(5): 641 - 651.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
P. M. Miller, M. C. Ravenel, A. E. Shealy, and S. Thomas
Alcohol screening in dental patients: The prevalence of hazardous drinking and patients' attitudes about screening and advice
J Am Dent Assoc, December 1, 2006; 137(12): 1692 - 1698.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. H. Westra and D. Sidransky
Fluorescence Visualization in Oral Neoplasia: Shedding Light on an Old Problem.
Clin. Cancer Res., November 15, 2006; 12(22): 6594 - 6597.
[Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
B. W. Neville, A. C. Chi, and M. Jeter
A red lesion on the palate.
J Am Dent Assoc, November 1, 2006; 137(11): 1537 - 1538.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Huang, M. R. Spitz, J. Gu, J.J. Lee, J. Lin, S. M.Lippman, and X. Wu
Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions
Carcinogenesis, October 1, 2006; 27(10): 2034 - 2037.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Hsu, Y.-C. Shen, C.-C. Cheng, R.-L. Hong, C.-J. Chang, and A.-L. Cheng
Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in taiwan: implication from age-period-cohort analysis.
Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 856 - 861.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Gelbard, C. T. Garnett, S. I. Abrams, V. Patel, J. S. Gutkind, C. Palena, K.-Y. Tsang, J. Schlom, and J. W. Hodge
Combination Chemotherapy and Radiation of Human Squamous Cell Carcinoma of the Head and Neck Augments CTL-Mediated Lysis.
Clin. Cancer Res., March 15, 2006; 12(6): 1897 - 1905.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Yang, K. Yang, A. Khafagi, Y. Tang, T. E. Carey, A. W. Opipari, R. Lieberman, P. A. Oeth, W. Lancaster, H. P. Klinger, et al.
Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies
PNAS, May 24, 2005; 102(21): 7683 - 7688.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
L. L. PATTON, J. R. ELTER, J. H. SOUTHERLAND, and R. P. STRAUSS
Knowledge of oral cancer risk factors and diagnostic concepts among North Carolina dentists: Implications for diagnosis and referral
J Am Dent Assoc, May 1, 2005; 136(5): 602 - 610.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. V. Shurin, R. Ferris, I. L. Tourkova, L. Perez, A. Lokshin, L. Balkir, B. Collins, G. S. Chatta, and M. R. Shurin
Loss of New Chemokine CXCL14 in Tumor Tissue Is Associated with Low Infiltration by Dendritic Cells (DC), while Restoration of Human CXCL14 Expression in Tumor Cells Causes Attraction of DC Both In Vitro and In Vivo
J. Immunol., May 1, 2005; 174(9): 5490 - 5498.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. J. Franzmann, E. P. Reategui, K. L. Carraway, K. L. Hamilton, D. T. Weed, and W. J. Goodwin
Salivary Soluble CD44: A Potential Molecular Marker for Head and Neck Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 735 - 739.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
G. F. CANNICK, A. M. HOROWITZ, T. F. DRURY, S. G. REED, and T. A. DAY
Assessing oral cancer knowledge among dental students in South Carolina
J Am Dent Assoc, March 1, 2005; 136(3): 373 - 378.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S.-L. Lu, D. Reh, A. G. Li, J. Woods, C. L. Corless, M. Kulesz-Martin, and X.-J. Wang
Overexpression of Transforming Growth Factor {beta}1 in Head and Neck Epithelia Results in Inflammation, Angiogenesis, and Epithelial Hyperproliferation
Cancer Res., July 1, 2004; 64(13): 4405 - 4410.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. L. Mulshine, J. C. Atkinson, R. O. Greer, V. A. Papadimitrakopoulou, C. Van Waes, S. Rudy, J. W. Martin, S. M. Steinberg, D. J. Liewehr, I. Avis, et al.
Randomized, Double-Blind, Placebo-Controlled Phase IIB Trial of the Cyclooxygenase Inhibitor Ketorolac as an Oral Rinse in Oropharyngeal Leukoplakia
Clin. Cancer Res., March 1, 2004; 10(5): 1565 - 1573.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by American Cancer Society.